Trio Acucap is a combination inhalation therapy used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. It contains:
Vilanterol 25 mcg: A long-acting beta₂-adrenergic agonist (LABA) that helps relax the muscles in the airways to improve airflow.
Umeclidinium 62.5 mcg: A long-acting muscarinic antagonist (LAMA) that works to open the airways by blocking acetylcholine.
Fluticasone Furoate 100 mcg: A corticosteroid with anti-inflammatory properties that reduces swelling and inflammation in the airways.